ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 410 filers reported holding ENCOMPASS HEALTH CORP in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $601,918 | +31.1% | 8,943 | +32.1% | 0.00% | +100.0% |
| Q2 2023 | $459,247 | +33.9% | 6,768 | +48.7% | 0.00% | -80.0% |
| Q3 2021 | $343,000 | -3.7% | 4,552 | +0.1% | 0.01% | 0.0% |
| Q2 2021 | $356,000 | -5.6% | 4,546 | -0.8% | 0.01% | -16.7% |
| Q1 2021 | $377,000 | -5.3% | 4,583 | -4.5% | 0.01% | 0.0% |
| Q4 2020 | $398,000 | -12.3% | 4,800 | -30.9% | 0.01% | -25.0% |
| Q3 2020 | $454,000 | -32.9% | 6,949 | -36.2% | 0.01% | -46.7% |
| Q2 2020 | $677,000 | -82.5% | 10,890 | -81.9% | 0.02% | -87.3% |
| Q1 2020 | $3,865,000 | -32.5% | 60,102 | -27.0% | 0.12% | -23.9% |
| Q4 2019 | $5,727,000 | -13.6% | 82,329 | -21.3% | 0.16% | -23.6% |
| Q3 2019 | $6,625,000 | -38.9% | 104,664 | -38.9% | 0.20% | -39.9% |
| Q2 2019 | $10,851,000 | +10041.1% | 171,236 | +41.0% | 0.34% | +8350.0% |
| Q1 2019 | $107,000 | +105.8% | 121,425 | +14476.8% | 0.00% | +33.3% |
| Q4 2018 | $52,000 | – | 833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |